´«¹°»ù »óÇÇÁ¾¾çÀÇ ÀÓ»óÀû ºÐ¼®
Clinical Analysis of Epithelial Tumors of the Lacrimal Gland
´ëÇѾȰúÇÐȸÁö 2014³â 55±Ç 6È£ p.795 ~ p.800
¿øÀ翬(Won Jae-Yon) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¾È°ú ¹× ½Ã°úÇб³½Ç
Á¤¼ö°æ(Jung Su-Kyung) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¾È°ú ¹× ½Ã°úÇб³½Ç
¹éÁö¼±(Paik Ji-Sun) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¾È°ú ¹× ½Ã°úÇб³½Ç
¾ç¼®¿ì(Yang Suk-Woo) - °¡Å縯´ëÇб³ Àǰú´ëÇÐ ¾È°ú ¹× ½Ã°úÇб³½Ç
Abstract
¸ñÀû: ´«¹°»ù »óÇÇÁ¾¾ç ȯÀÚÀÇ ÀÓ»ó ¾ç»ó°ú ¹æ»ç¼± ¼Ò°ßÀ» ºÐ¼®Çϰí Ä¡·á ¹× ¿¹ÈÄ¿¡ ´ëÇÏ¿© ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.
´ë»ó°ú ¹æ¹ý: 2005³â 5¿ùºÎÅÍ 2012³â 10¿ù±îÁö º»¿ø¿¡¼ Á¶Á÷»ý°ËÀ̳ª ¿Ü°úÀû ÀýÁ¦ ÈÄ º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ´«¹°»ù »óÇÇÁ¾¾çÀ¸·Î È®Áø ¹ÞÀº 36¸í ȯÀÚÀÇ Àǹ«±â·ÏÀ» ÈÄÇâÀûÀ¸·Î °íÂûÇÏ¿´´Ù.
°á°ú: ÃÑ 36¸íÀÇ ´«¹°»ù »óÇÇÁ¾¾ç Áß º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ´ÙÇü¼º ¼±Á¾ 21¿¹, ´«¹°»ù³¶ 7¿¹, ¼±³¶¾ÏÁ¾ 4¿¹, ¼±¾ÏÁ¾ 2¿¹, ¾ç¼º È£»ê¼º °ú¸³ ¼¼Æ÷Á¾ 1¿¹, Á¡¾×Ç¥ÇÇ¾ç ¾ÏÁ¾ÀÌ 1¿¹¿´´Ù. °¡Àå ÈçÇÑ Áõ»óÀº ¾È±¸µ¹Ãâ(52.7%)À̾ú°í ¾Ç¼º´«¹°»ù»óÇÇÁ¾¾çÀº ¾ç¼º´«¹°»ù»óÇÇÁ¾¾ç¿¡ ºñÇØ ¾È±¸¿îµ¿ Àå¾Ö ¹× º¹½Ã(57.1%), ¾È±¸ ÅëÁõ(42.9%), ½Ã·Â ÀúÇÏ(42.9%)°¡ Ư¡ÀûÀÎ Áõ»óÀ̾ú´Ù. Æò±ÕÁõ»ó ¹ßÇö±â°£µµ ¾Ç¼º´«¹°»ù»óÇÇÁ¾¾ç (5.0 ¡¾ 4.2°³¿ù)Àº ¾ç¼º´«¹°»ù»óÇÇÁ¾¾ç(11.2 ¡¾ 11.1°³¿ù)¿¡ ºñÇÏ¿© ª¾Ò´Ù(t-test, p=0.034). Àü»êÈ´ÜÃþÃÔ¿µ°ú ÀÚ±â°ø¸í¿µ»ó¿¡¼ ´ÙÇü ¼º¼±Á¾ 2¿¹(9.5%)¿¡¼ °æÇÑ °ñÆÄ±« ¼Ò°ß°ú 1¿¹(3.4%)¿¡¼ ¼®È¸È°¡ °üÂûµÈ °ÍÀ» Á¦¿ÜÇϰí´Â, ¾Ç¼º ´«¹°»ù »óÇÇÁ¾¾çÀº ¾ç¼º´«¹°»ù»óÇÇ Á¾¾ç°ú ºñ±³ÇÏ¿© Ư¡ÀûÀÎ °ñÆÄ±« ¼Ò°ß(57.1%), Á¾¾çÀÇ °æ°è°¡ ºÒÈ®½ÇÇÑ °æ¿ì(42.9%) ±×¸®°í ¼®È¸È(14.3%)°¡ °üÂûµÇ¾ú´Ù. ¾Ç¼º´«¹°»ù »óÇÇÁ¾¾çÀº ¿Ü°úÀû ÀýÁ¦¼ú ÈÄ ¹æ»ç¼± Ä¡·á ¹× Ç×¾ÏÄ¡·á¸¦ 57.1%¿¡¼ ¹Þ¾ÒÀ¸¸ç ±×Áß 1¿¹(14.3%)¿¡¼ Ä¡·á ÈÄ Àç¹ß¼Ò°ßÀ» º¸¿´´Ù.
°á·Ð: ´«¹°»ù»óÇÇÁ¾¾ç ȯÀÚÀÇ ÀÓ»óÁõ»ó ¹× ¹æ»ç¼± ¼Ò°ßÀ» ÁÖÀÇ ±í°Ô ºÐ¼®ÇÏ¸é ¾Ç¼ºÁ¾¾çÀ» Á¶±â Áø´ÜÇÏ´Â µ¥ µµ¿òÀ» ÁÙ ¼ö ÀÖÀ» °ÍÀ¸·Î »ý°¢ÇÑ´Ù.
Purpose: To analyze the clinical and radiologic findings and to evaluate the treatment and prognosis of epithelial tumor patients.
Methods: We retrospectively reviewed clinical and radiologic findings of 36 patients who had been histopathologically diagnosed with epithelial tumors of the lacrimal gland after biopsy and surgery at Seoul St. Mary¡¯s Hospital from May 2005 to October 2012.
Results: Among the patients with epithelial tumors of the lacrimal gland based on histopathological findings, there were 21 cases of pleomorphic adenoma, seven cases of dacryops, four cases of adenoid cystic carcinoma, two cases of adenocarcinoma, one case of benign oncocytoma, and one case of mucoepidermoid carcinoma. The characteristic clinical finding of epithelial tumors of the lacrimal gland was proptosis (52.7%). In contrast with benign epithelial tumors of the lacrimal gland, the characteristic clinical findings of malignant epithelial tumors of the lacrimal gland were limitation of motion (57.1%), diplopia (57.1%), ocular pain (42.9%), and decreased visual acuity (42.9%). The mean duration of the symptoms of malignant epithelial tumors (5.0 ¡¾ 4.2 months) was shorter than that of benign epithelial tumors (11.2 ¡¾ 11.1 months) (t-test, p = 0.034). In radiologic CT and MRI findings, there was minimal bony destruction in two cases of pleomorphic adenoma and calcification in one case of pleomorphic adenoma. Malignant epithelial tumors of the lacrimal gland, in contrast to benign tumors, showed characteristic bony destruction (57.1%), poorly marginated tumor outline (42.9%) and calcification (14.3%). The 57.1% of patients in this study with malignant tumors were treated with chemotherapy and radiotherapy after surgical treatment, and there was one case (14.3%) of recurrence after treatment.
Conclusions: Careful analysis of clinical and radiologic findings can lead to early diagnosis of malignant tumors.
Ű¿öµå
Clinical findings, Epithelial tumors of the lacrimal gland, Radiologic findings
KMID :
0360220140550060795
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)